3648 results for «2443»
3648 results
From probe to patient: understanding echocardiography in structural heart disease
22 May 2025 – From EuroPCR 2025
Build foundational knowledge of echocardiography in structural heart disease. This session covers basic principles, diagnostic approaches correlating symptoms with valvular disease, and the vital role of echocardiography in post-procedural assessment and follow-up.
TAVI - Head-to-head comparative studies
22 May 2025 – From EuroPCR 2025
Compare head-to-head outcomes of various TAVI devices through real-world registries and meta-analyses. This session provides insights into performance differences between self-expanding and balloon-expandable valves to inform clinical decision-making.
Pulmonary embolism - What should we do in the cathlab?
22 May 2025 – From EuroPCR 2025
Explore this session focused on pulmonary embolism management in the cathlab, highlighting when pharmacotherapy is insufficient and reviewing interventional options anticipated in 2025. Engage with real cases including polytrauma with acute respiratory failure and complex presentations like pre-syncope and scoliosis, accompanied by expert discussions and key...
Best companion's cases on orbital atherectomy
22 May 2025 – From EuroPCR 2025
Dive into advanced cases demonstrating orbital atherectomy techniques for managing challenging calcified coronary lesions. This session includes innovative approaches such as 'sand and knock' calcium modification, orbital atherectomy in complex anatomies, and the use of optical coherence tomography to guide percutaneous treatment of calcified nodules.
Mitral abstracts session
22 May 2025 – From EuroPCR 2025
Examine critical mitral valve research through a series of abstracts focusing on mitral TEER outcomes. Topics include the impact of mitral valve complexity, prognostic significance of right atrial pressure, comparative analysis of degenerative versus functional mitral regurgitation, and validation of risk scores, providing valuable insights for...
Novelty in ACS diagnosis and treatment
22 May 2025 – From EuroPCR 2025
Discover novel diagnostic and therapeutic advances in acute coronary syndrome (ACS) management. This session covers innovative topics such as paclitaxel-coated balloon angioplasty safety in STEMI, the prognostic role of carbon monoxide, AI-based ECG prediction of infarct-related arteries, microcirculatory resistance indices in MINOCA, and real-world optical coherence...
360 management of cardiogenic shock
22 May 2025 – From EuroPCR 2025
This session presents a comprehensive 360-degree approach to managing cardiogenic shock, featuring long-term outcomes of low-profile ventricular assist devices, emergency ECMO implementation in PCI centers without on-site surgery, and pharmacologic strategies comparing cangrelor and ticagrelor efficacy and safety in acute myocardial infarction complicated by cardiogenic shock...
CTO PCI evolution: unlocking new approaches
22 May 2025 – From EuroPCR 2025
Unlock new approaches in chronic total occlusion (CTO) PCI with this session highlighting advanced techniques such as tip-in methods when microcatheters fail, support maximization strategies, rotational direction considerations during CTO, and timing of PCI in ACS patients with non-infarct related CTOs.
TAVI new devices
22 May 2025 – From EuroPCR 2025
Explore the latest innovations in transcatheter aortic valve implantation (TAVI) devices with a focus on coronary protection strategies, cerebral embolic protection integration, management of ventricular migration, and overcoming anatomical challenges such as bicuspid and rheumatic valve disease using novel platforms.
What an interventional cardiologist should know about anti-thrombotics
22 May 2025 – From EuroPCR 2025
This session provides comprehensive knowledge on anti-thrombotic management for interventional cardiologists, emphasizing effective inhibition during acute STEMI, latest evidence implementation for high bleeding risk patients, and customization of dual antiplatelet therapy in patients with high thrombotic and low bleeding risks through clinical cases and evidence-based recommendations.
Clinical and technical factors for decision-making in treatment of left main coronary artery disease
22 May 2025 – From EuroPCR 2025
Delve into decision-making factors in treating left main coronary artery disease, particularly in challenging scenarios. This session discusses the application of new SOLACI guidelines, critical strategy reflections, and real-world cases illustrating optimal left main PCI approaches.
A tale of two branches: lessons from complex bifurcation PCI
21 May 2025 – From EuroPCR 2025
Delve into complex bifurcation PCI with detailed case studies illustrating practical approaches to challenging scenarios, including managing stent loss in stented left main bifurcations. Gain valuable lessons from retrograde CTO-PCI and true bifurcation lesions to enhance your procedural strategies.
Non-antiplatelet drugs interventionalists should be aware of
21 May 2025 – From EuroPCR 2025
Gain essential knowledge on non-antiplatelet drugs relevant to interventional cardiology. Topics include the effects of empagliflozin on oxidative stress, the impact of midazolam on radial spasm during primary PCI, pharmacological cocktails to prevent radial spasm, and hydration strategies in patients with kidney disease during cardiac catheterisation.
Streamlining the TAVI pathway
21 May 2025 – From EuroPCR 2025
Optimize your TAVI pathway through this session focusing on streamlined pre-procedural planning, minimalist procedural techniques, and post-procedural discharge strategies. Learn how to safely deliver multiple cases per list and implement next-day or same-day discharge programs effectively.
Challenging vascular access and closure management
21 May 2025 – From EuroPCR 2025
Address challenging vascular access and closure management in complex TAVI cases. This session covers the selection of femoral access, use of PTA and intravascular lithotripsy, and strategies to manage closure failure with illustrative real-world cases.
DCB after REC-CAGEFREE 1 - Vulnerable plaque PCI after PREVENT
21 May 2025 – From EuroPCR 2025
Reflect on the impact of recent trials REC-CAGEFREE 1 and PREVENT on the use of drug-coated balloons (DCB) and preventive PCI for vulnerable plaque. This session includes case discussions highlighting DCB applications and insights from cutting-edge clinical studies.
Hotline TAVI 1: extended analysis of the randomised trials
21 May 2025 – From EuroPCR 2025
Gain comprehensive insights from extended analyses of randomized TAVI trials. This session reviews five-year UK TAVI outcomes, cardiac damage evolution in asymptomatic aortic stenosis, one-year results from the LANDMARK trial, and three-year comparisons of balloon-expandable valves, highlighting critical clinical implications.
ACS with normal coronary arteries: angiography done, job done?
21 May 2025 – From EuroPCR 2025
Understand the clinical significance of MINOCA and learn diagnostic strategies integrating invasive and non-invasive tests to identify underlying etiologies. This session provides therapeutic insights tailored to specific MINOCA endotypes through illustrative cases.
How to avoid and manage complications in CTO interventions
21 May 2025 – From EuroPCR 2025
Learn how to anticipate, prevent, and manage complications during complex CTO interventions. This session presents real-world cases including donor artery dissection, main and distal vessel perforations, and the importance of teamwork in the cath lab for successful complication management.
Optimising CTO outcomes by lesion selection
21 May 2025 – From EuroPCR 2025
Optimize chronic total occlusion (CTO) PCI outcomes through lesion selection strategies. This session reviews coronary calcium patterns via CT, target vessel considerations, distal vessel remodeling, imaging-guided versus conventional approaches, and complex lesion cases.
